Skip Navigation

This Article
Right arrow Print PDF (5209K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Abendroth, F. D.
Right arrow Articles by Dynan, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abendroth, F. D.
Right arrow Articles by Dynan, W. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1995, Vol. 23, No. 14 2770-2774
© 1995


MOLECULAR BIOLOGY

Identification of human autoantibodies to transcription factor IIB

Francena D. Abendroth, Scott R. Peterson, Matthew Galman, Akira Suwa1,+, John A. Hardin1 and William S. Dynan*

Department of Chemistry and Biochemistry, Campus Box 215, University of Colorado Boulder, CO 80309, USA 1Department of Medicine, Medical College of Georgia 1120 15th Street, Augusta, GA 30912, USA

*To whom correspondence should be addressed

Received March 3, 1995. Accepted June 13, 1995.

We have characterized the ability of various human autoimmune sera to react with RNA polymerase II transcription factors. One serum, which strongly Inhibited transcription in a cell-free system, was shown to contain antibodies directed against human TFIIB. The serum did not show reactivity against the other general transcription factors, including human TBP, TRIE and TF1IF. The inhibition of transcription was directly attributable to depletion of TFIIB activity, as demonstrated by reconstftution of activity with recombinant TFIIB. It has long been recognized that components of the RNA processing machinery are major human autoantigens. The present results show that at least one general transcription factor required for messenger RNA synthesis Is an autoantigen as well.


+Present address: Division of Rheumatic Diseases, Tokyo Metropolitan Ohtsuka Hospital, Tokyo 170, Japan


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.